BRPI0720794A2 - Vacina de peptideo foxp3 - Google Patents

Vacina de peptideo foxp3 Download PDF

Info

Publication number
BRPI0720794A2
BRPI0720794A2 BRPI0720794-8A BRPI0720794A BRPI0720794A2 BR PI0720794 A2 BRPI0720794 A2 BR PI0720794A2 BR PI0720794 A BRPI0720794 A BR PI0720794A BR PI0720794 A2 BRPI0720794 A2 BR PI0720794A2
Authority
BR
Brazil
Prior art keywords
peptide
foxp3
seq
cells
peptides
Prior art date
Application number
BRPI0720794-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Tsunoda Takuya
Osawa Ryuji
Original Assignee
Oncotherapy Science, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science, Inc. filed Critical Oncotherapy Science, Inc.
Publication of BRPI0720794A2 publication Critical patent/BRPI0720794A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0720794-8A 2007-01-03 2007-12-26 Vacina de peptideo foxp3 BRPI0720794A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87861507P 2007-01-03 2007-01-03
US60/878,615 2007-01-03
US89647207P 2007-03-22 2007-03-22
US60/896,472 2007-03-22
PCT/JP2007/001466 WO2008081581A1 (en) 2007-01-03 2007-12-26 Foxp3 peptide vaccine

Publications (1)

Publication Number Publication Date
BRPI0720794A2 true BRPI0720794A2 (pt) 2014-03-11

Family

ID=39588270

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0720794-8A BRPI0720794A2 (pt) 2007-01-03 2007-12-26 Vacina de peptideo foxp3

Country Status (14)

Country Link
US (1) US8563516B2 (enExample)
EP (2) EP2114987A4 (enExample)
JP (1) JP5339375B2 (enExample)
KR (1) KR20090099075A (enExample)
CN (1) CN101641369B (enExample)
AU (1) AU2007340834B2 (enExample)
BR (1) BRPI0720794A2 (enExample)
CA (1) CA2674365A1 (enExample)
IL (1) IL199622A0 (enExample)
MX (1) MX2009007261A (enExample)
RU (1) RU2473557C2 (enExample)
SG (1) SG177199A1 (enExample)
TW (1) TWI441648B (enExample)
WO (1) WO2008081581A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009050486A2 (en) * 2007-10-19 2009-04-23 The University Of Surrey Peptide manipulators of regulatory t cell activity
CZ2008565A3 (cs) * 2008-09-15 2009-11-18 Vysoká škola chemicko technologická v Praze Príprava monoklonálních protilátek proti FoxP3 proteinu s použitím modifikovaných virum podobných cástic Masonova-Pfizerova opicího viru
KR20110117112A (ko) * 2008-12-24 2011-10-26 온코세라피 사이언스 가부시키가이샤 Ｃ１ｏｒｆ５９ 펩티드 및 이를 포함하는 백신
TWI507204B (zh) * 2009-05-26 2015-11-11 Oncotherapy Science Inc Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
US9458447B2 (en) * 2011-08-12 2016-10-04 Oncotherapy Science, Inc. MPHOSPH1 peptides and vaccines including the same
CN102603892B (zh) * 2012-02-22 2013-10-30 尉军 一种肿瘤标志物foxp3抗原多肽及应用
US11505599B2 (en) * 2016-01-14 2022-11-22 Memorial Sloan-Kettering Cancer Center T cell receptor-like antibodies specific for Foxp3-derived peptides
CN111375055B (zh) * 2020-02-20 2021-09-03 陈宛莎 一种2019-nCoV亚单位疫苗组合物及其免疫方法
CN122438694A (zh) * 2023-12-19 2026-07-21 瑞泽恩制药公司 Foxp3肽及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE922436A1 (en) 1991-07-25 1993-01-27 Idec Pharma Corp Induction of cytotoxic t-lymphocyte responses
US7507542B2 (en) 2001-05-08 2009-03-24 Ucb Sa Method for regulating immune function using the FOXP3 protein
EP2267023B1 (en) 2002-09-12 2015-02-11 Oncotherapy Science, Inc. KDR peptides and vaccines comprising the same
GB0417430D0 (en) * 2004-08-05 2004-09-08 Uc3 A novel HPV vaccine comprising peptides from host cell proteins
JP4628208B2 (ja) * 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Ｃｘａｄｒｌ１またはｇｃｕｄ１タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
JP4840866B2 (ja) 2005-01-19 2011-12-21 学校法人慶應義塾 癌ワクチン

Also Published As

Publication number Publication date
EP2114987A1 (en) 2009-11-11
TWI441648B (zh) 2014-06-21
EP2481748A3 (en) 2012-10-24
US8563516B2 (en) 2013-10-22
CN101641369A (zh) 2010-02-03
MX2009007261A (es) 2009-11-11
AU2007340834A1 (en) 2008-07-10
IL199622A0 (en) 2010-04-15
EP2481748A2 (en) 2012-08-01
US20100092501A1 (en) 2010-04-15
CN101641369B (zh) 2014-10-22
RU2009129531A (ru) 2011-02-10
RU2473557C2 (ru) 2013-01-27
TW200835516A (en) 2008-09-01
AU2007340834B2 (en) 2013-02-28
CA2674365A1 (en) 2008-07-10
JP2010514669A (ja) 2010-05-06
SG177199A1 (en) 2012-01-30
WO2008081581A1 (en) 2008-07-10
JP5339375B2 (ja) 2013-11-13
KR20090099075A (ko) 2009-09-21
EP2114987A4 (en) 2010-07-21

Similar Documents

Publication Publication Date Title
US9545437B2 (en) Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
CN103351423B (zh) 用于表达肿瘤相关抗原的癌症的肽疫苗
TWI434853B (zh) 腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
US8617562B2 (en) FOXM1 peptides and immunogenic compositions containing them
US8563516B2 (en) Foxp3 peptide vaccine
SG191680A1 (en) Cdca1 epitope peptides and vaccines containing the same
AU2009258788A1 (en) IQGAP3 epitope peptides and vaccines containing the same
US20110189213A1 (en) Mybl2 epitope peptides and vaccines containing the same
BRPI0919766B1 (pt) Oligopeptídeo, seu uso, agente farmacêutico ou composição para o tratamento e/ou profilaxia de câncer, e/ou prevenção de recorrência pósoperatória do mesmo, métodos in vitro para induzir uma célula apresentadora de antígeno e para induzir um ctl
JP5764823B2 (ja) Ｗｄｒｐｕｈエピトープペプチドおよびそれを含むワクチン
AU2008238739B2 (en) TEM8 peptides and vaccines comprising the same
HK1174337A (en) Foxp3 peptide vaccine

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]

Free format text: ALTERACAO DE DADOS CADASTRAIS NO INID (54).